Gemcitabine, Doxorubicin and Paclitaxel (GAT)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Gemcitabine, Doxorubicin and Paclitaxel (GAT), covering 2023-03-06 to 2023-03-06. Get the full timeline:
Most recent: Clinical Trial Update: Gemcitabine, Doxorubicin and Paclitaxel (GAT) as Neoadjuvant Treatment of Breast Cancer Patients [Phase 2]